CRYM and amyotrophic lateral sclerosis: Although mutant SOD1 silencing in Crym-positive UMNs did not affect disease onset or outcome, in contrast to LMN suppression, this study highlights the usefulness of Crym as a potential UMN selective marker for ALS research.